Cultured podocytes with a higher DLX6-AS1 expression exhibited a damaged phenotype and inflammatory responses through the miR-346-mediated regulation of the GSK-3β pathway, contributing to the progression of diabetic nephropathy [51]. The gene discussed is DLX6; the disease is diabetic kidney disease.